Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Horizon Lines: A Quarterly Review of NDAs – October- December 2025
This quarterly review of New Drug Applications contains data for applications approved for the first time during the last quarter of 2025, which includes New Molecular Entities (NMEs) and new biologics. A total of 40 applications were approved by the FDA during these three months. read more
Hasty Decisions, Runaway Projects
Despite the best intentions of ISO and EMA, the pharma industry is still largely failing to exploit its data in a strategic, joined-up way - and this could now restrict companies’ ability to capitalize on AI. read more
An Interview With Brian Morrissey
In this interview we spoke to Brian Morrissey, General Manager of Gaelic Laboratories, about the strategy behind their acquisition of Athlone Laboratories, and its impact. read more
Material-Sparing Strategies for Rapid Development and Scale-Up of Complex Drug Products
In an industry where complex molecules and first-in-human (FIH) formulations often come with very limited API supply, material-sparing strategies are central to efficient CMC development. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Halozyme Appoints David Ramsay as President Drug Delivery
Wednesday, July 01, 2026
Halozyme Therapeutics announced the appointment of David Ramsay as President Drug Delivery, effective June 30, 2026. read more
Rezon Bio Appoints Chief Business Officer to Accelerate Global Commercial Expansion
Wednesday, July 01, 2026
Rezon Bio announced the appointment of Dr. Hubert Scholze as Chief Business Officer (CBO), effective July 1, 2026. read more
Rentschler Biopharma Appoints Chief Executive Officer
Wednesday, July 01, 2026
Rentschler Biopharma SE announced the appointment of Torsten Woehr as Chief Executive Officer (CEO), effective August 1, 2026. read more
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration
Tuesday, June 30, 2026
AustinPx announced its agreement with Thermo Fisher Scientific’s Patheon pharma services for the installation of AustinPx’s KinetiSol™ Technology ... read more
Lonza to Add ADC Payload-Linker Capacity at Visp
Tuesday, June 30, 2026
Lonza plans to expand payload-linker manufacturing capacity at its Visp, Switzerland, site to meet rising demand in the fast-growing antibody-drug ... read more